Company search
Investment trusts: the treatments and takeovers behind the biotech boom
From cancer to depression, new medicines will transform health outcomes.
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Related articles
Fantasy fund manager: it’s a photo finish for the top spot
As the 2025 competition draws to a close, the top two contestants have made almost 30% in just 12 months.
What are the risks for investors in 2026?
Investment trust managers comment on what keeps them awake at night.
Related videos
303: Money Makers Investment Trusts Podcast - The biotech sector (01 Nov 2025)
In this edition of the Money Makers Investment Trusts Podcast, Jonathan Davis, takes a look at the biotech sector and speaks to Woody Stileman, London officer manager at RTW Biotech, managers of RTW Biotech Opportunities (RTW); Geoffrey Hsu, manager of Biotech Growth Trust (IBT); and Ailsa Craig, co-manager of International Biotechnology Trust (BIOG).
Related industry news
RTW Biotech Opportunities delivers fourth reverse merger of 2026
Biotech’s fundraising and M&A bonanza continues to boost the specialist funds invested in this exciting growth industry.
Morning briefing: Riverstone Energy writes down Group14, RTW portfolio company lists in reverse merger, plus AIRE
Riverstone Energy (RSE) has written down Group14 Technologies to zero following ongoing production and commissioning challenges, as it continues its m...
Biotech Growth Trust boosted by Forte Biosciences buyout
Investment trust Biotech Growth (LON:BIOG) received another boost after Forte Biosciences (NASDAQ:FBRX) agreed a $2.2 billion takeover by Argenx (EBR:ARGX), a Belgian-Dutch pharmaceutical company.
Biotech Growth makes 14-times return on Forte Biosciences accepting $2.2bn bid from Argenx SE
Biotech Growth (BIOG) has bagged its second bid for a company in a month with Forte Biosciences, a US immunological drug developer accounting for 3% o...
Investment company news brought to you by Citywire Financial Publishers Limited,
QuotedData by Marten & Co, Sharesify, and the armchair trader.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
